The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves
Abstract
BACKGROUND: Tissue engineering is a new approach in which techniques are being developed to transplant autologous cells onto biodegradable scaffolds to ultimately form new functional autologous tissue. Workers at our laboratory have focused on tissue engineering of heart valves. The present study was designed to evaluate the implantation of a whole trileaflet tissue-engineered heart valve in the pulmonary position in a lamb model. METHODS AND RESULTS: We constructed a biodegradable and biocompatible trileaflet heart valve scaffold that was fabricated from a porous polyhydroxyalkanoate (pore size 180 to 240 microm; Tepha Inc). Vascular cells were harvested from ovine carotid arteries, expanded in vitro, and seeded onto our heart valve scaffold. With the use of cardiopulmonary bypass, the native pulmonary leaflets were resected, and 2-cm segments of pulmonary artery were replaced by autologous cell-seeded heart valve constructs (n=4). One animal received an acellular valved conduit. No animal received any anticoagulation therapy. Animals were killed at 1, 5, 13, and 17 weeks. Explanted valves were examined histologically with scanning electron microscopy, biochemically, and biomechanically. All animals survived the procedure. The valves showed minimal regurgitation, and valve gradients were <20 mm Hg on echocardiography. The maximum gradient was 10 mm Hg with direct pressures. Macroscopically, the tissue-engineered constructs were covered with tissue, and there was no thrombus formation on any of the specimens. Scanning electron microscopy showed smooth flow surfaces during the follow-up period. Histological examination demonstrated laminated fibrous tissue with predominant glycosaminoglycans as extracellular matrix. 4-Hydroxyproline assays demonstrated an increase in collagen content as a percentage of native pulmonary artery (1 week 45.8%, 17 weeks 116%). DNA assays showed a comparable number of cells in all explanted samples. There was no tissue formation in the acellular control. CONCLUSIONS: Tissue-engineered heart valve scaffolds fabricated from polyhydroxyalkanoates can be used for implantation in the pulmonary position with an appropriate function for 120 days in lambs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
Self-citationFunctional Arteries Grown in Vitro
Niklason, L. E., Gao, J., Abbott, W. M., Hirschi, K. K., Houser, S., Marini, R., & Langer, R. (1999) · Science · doi:10.1126/science.284.5413.489 · Cited by 1,766
Two Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525
Vacanti, J. P., & Langer, R. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90247-7 · Cited by 1,323
Self-citationThromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Cannegieter, S. C., Rosendaal, F. R., & Briët, E. (1994) · Circulation · doi:10.1161/01.cir.89.2.635 · Cited by 1,068
Vongpatanasin, W., Hillis, L. D., & Lange, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350607 · Cited by 811
Tissue heart valves: Current challenges and future research perspectives
Schoen, F. J., & Levy, R. J. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19991215)47:4<439::aid-jbm1>3.0.co;2-o · Cited by 498
Self-citationTissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka, T., Ma, P. X., Shum‐Tim, D., Breuer, C. K., Cusick, R. A., Zünd, G., Langer, R., Vacanti, J. P., & Mayer, J. E. (1996) · PubMed · Cited by 246
Self-citationLong-term function of cryopreserved aortic homografts
Kirklin, J. K., Smith, D., Novick, W., Naftel, D. C., Kirklin, J. W., Pacifico, A. D., Nanda, N. C., Helmcke, F. R., & Bourge, R. C. (1993) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33752-3 · Cited by 229
Sodian, R., Sperling, J. S., Martin, D. P., Egozy, A., Stock, U., Mayer, J. E., & Vacanti, J. P. (2000) · Tissue Engineering · doi:10.1089/107632700320793 · Cited by 201
Self-citation
Cited by
Management of acute myocardial infarction in patients presenting with ST-segment elevation
VandeWerf, F. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00618-8 · Cited by 1,448
The application of polyhydroxyalkanoates as tissue engineering materials
Chen, G.-Q., & Wu, Q. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.04.036 · Cited by 1,418
Hockaday, L. A., Kang, K. H., Colangelo, N. W., Cheung, P. Y. C., Duan, B., Malone, E., Wu, J., Girardi, L. N., Bonassar, L. J., Lipson, H., et al. (2012) · Biofabrication · doi:10.1088/1758-5082/4/3/035005 · Cited by 683
Elastomeric biomaterials for tissue engineering
Chen, Q., Liang, S., & Thouas, G. A. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.05.003 · Cited by 564
Medical applications of poly-4-hydroxybutyrate: A strong flexible absorbable biomaterial
Martin, D. P., & Williams, S. F. (2003) · Biochemical Engineering Journal · doi:10.1016/s1369-703x(03)00040-8 · Cited by 510
Self-citation
Metadata
- Authors
- Sodian, R., Hoerstrup, S. P., Sperling, J. S., Daebritz, S., Martin, D. P., Moran, A. M., Kim, B. S., Schoen, F. J., Vacanti, J. P., & Mayer, J. E.
- Venue
- Circulation
- Published
- 2000-11-07
- Volume
- 102
- Issue
- Supplement 3
- Pages
- III-22-III-29
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2143758769
- Cited by
- 330
- References
- 16
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves. https://app.cochat.ai/papers/10.1161/01.cir.102.suppl_3.iii-22
- The paper
- Sodian, R., Hoerstrup, S. P., Sperling, J. S., Daebritz, S., Martin, D. P., Moran, A. M., Kim, B. S., Schoen, F. J., Vacanti, J. P., & Mayer, J. E. (2000). Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves. Circulation. https://doi.org/10.1161/01.cir.102.suppl_3.iii-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.